Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493152-24-032563
Filing Date
2024-08-15
Accepted
2024-08-15 12:53:48
Documents
4

Document Format Files

Seq Description Document Type Size
1 formsc13da.htm SC 13D/A 57095
2 ex99-1.htm EX-99.1 828667
3 ex99-2.htm EX-99.2 37645
4 ex99-3.htm EX-99.3 161780
  Complete submission text file 0001493152-24-032563.txt   1086885
Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017 (347) 627-0058
CITIUS ONCOLOGY, INC. (Subject) CIK: 0001851484 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93794 | Film No.: 241211391
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 420 LEXINGTON AVENUE SUITE 2446 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2446 NEW YORK NY 10170 917-398-5085
10XYZ Holdings LP (Filed by) CIK: 0001950963 (see all company filings)

EIN.: 871489189 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A